130 related articles for article (PubMed ID: 37301243)
1. Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.
Li L; Zou Y; Wang L; Yang L; Li Y; Liao A; Chen Z; Yu Z; Guo J; Han S
Int J Pharm; 2023 Jul; 642():123114. PubMed ID: 37301243
[TBL] [Abstract][Full Text] [Related]
2. Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma.
Yu Z; Guo J; Hu M; Gao Y; Huang L
ACS Nano; 2020 Apr; 14(4):4816-4828. PubMed ID: 32188241
[TBL] [Abstract][Full Text] [Related]
3. Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer.
Han S; Bi S; Guo T; Sun D; Zou Y; Wang L; Song L; Chu D; Liao A; Song X; Yu Z; Guo J
J Control Release; 2022 Aug; 348():250-263. PubMed ID: 35660631
[TBL] [Abstract][Full Text] [Related]
4. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer.
Sun D; Zou Y; Song L; Han S; Yang H; Chu D; Dai Y; Ma J; O'Driscoll CM; Yu Z; Guo J
Acta Pharm Sin B; 2022 Jan; 12(1):378-393. PubMed ID: 35127393
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Targeting NHC-Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma.
Yang Z; Bian M; Lv L; Chang X; Wen Z; Li F; Lu Y; Liu W
J Med Chem; 2023 Mar; 66(6):3934-3952. PubMed ID: 36827091
[TBL] [Abstract][Full Text] [Related]
6. Bio-responsive Au-miR-183 inhibitor enhances immunotherapy in hepatocellular carcinoma by inducing immunogenic cell death.
Yin L; Wei Y; Liu Y; Mo X; Song J; Cai W
J Control Release; 2024 Apr; 368():498-517. PubMed ID: 38428529
[TBL] [Abstract][Full Text] [Related]
7. Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression.
Cui Z; Li C; Liu W; Sun M; Deng S; Cao J; Yang H; Chen P
Cell Death Dis; 2024 Apr; 15(4):267. PubMed ID: 38622131
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
9. d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.
Han S; Bao X; Zou Y; Wang L; Li Y; Yang L; Liao A; Zhang X; Jiang X; Liang D; Dai Y; Zheng QC; Yu Z; Guo J
Sci Adv; 2023 Jul; 9(29):eadg2697. PubMed ID: 37467325
[TBL] [Abstract][Full Text] [Related]
10. A Chimeric Cetuximab-Functionalized Corona as a Potent Delivery System for Microtubule-Destabilizing Nanocomplexes to Hepatocellular Carcinoma Cells: A Focus on EGFR and Tubulin Intracellular Dynamics.
Poojari R; Kini S; Srivastava R; Panda D
Mol Pharm; 2015 Nov; 12(11):3908-23. PubMed ID: 26426829
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
Ha SE; Kim SM; Vetrivel P; Kim HH; Bhosale PB; Heo JD; Lee HJ; Kim GS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445559
[TBL] [Abstract][Full Text] [Related]
12. Systematic characterization of the tumor microenvironment in Chinese patients with hepatocellular carcinoma highlights intratumoral B cells as a potential immunotherapy target.
Feng Y; Liu L; Li J; Huang J; Xie JH; Menard L; Shi Y; Zhao X; Xie S; Zang W; Tan H; Yang Z; Ni L
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958112
[TBL] [Abstract][Full Text] [Related]
13. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy.
Li C; Wang L; Li Z; Li Z; Zhang K; Cao L; Wang Z; Shen C; Chen L
Int J Pharm; 2024 Feb; 651():123729. PubMed ID: 38142016
[TBL] [Abstract][Full Text] [Related]
14. Analyzing molecular typing and clinical application of immunogenic cell death-related genes in hepatocellular carcinoma.
Lin CF; Chen ZW; Kang FP; Hu JF; Huang L; Liao CY; Lai JL; Huang Y; Wang ZW; Tian YF; Chen S
BMC Cancer; 2023 Jun; 23(1):522. PubMed ID: 37291495
[TBL] [Abstract][Full Text] [Related]
15. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial cetuximab targeted polymeric nanocomplexes reduce PRC1 level and abrogate growth of metastatic hepatocellular carcinoma in vivo with efficient radionuclide uptake.
Poojari R; Mohanty B; Kadwad V; Suryawanshi D; Chaudhari P; Khade B; Srivastava R; Gupta S; Panda D
Nanomedicine; 2022 Apr; 41():102529. PubMed ID: 35104671
[TBL] [Abstract][Full Text] [Related]
17. SP94 Peptide-Functionalized PEG-PLGA Nanoparticle Loading with Cryptotanshinone for Targeting Therapy of Hepatocellular Carcinoma.
Nie X; Liu Y; Li M; Yu X; Yuan W; Huang S; Ren D; Wang Y; Wang Y
AAPS PharmSciTech; 2020 Apr; 21(4):124. PubMed ID: 32342227
[TBL] [Abstract][Full Text] [Related]
18. A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer.
Yao W; Ba Q; Li X; Li H; Zhang S; Yuan Y; Wang F; Duan X; Li J; Zhang W; Wang H
EBioMedicine; 2017 Aug; 22():58-67. PubMed ID: 28754304
[TBL] [Abstract][Full Text] [Related]
19. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Cell Oncol (Dordr); 2020 Dec; 43(6):1203-1214. PubMed ID: 32797385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
